Prostate Cancer
Newly Diagnosed With Prostate Cancer - How Aggressive Is Your Cancer
Estimate Your Risk
Very Low Risk
Low Risk
Intermediate Risk
High Risk
Very High Risk
Metastatic
Calculate
PSA:
Gleason Score:
Clinical Stage/Rectal Exam:
Note*:
Abnormal 1 : do not extend beyond prostate
Abnormal 2 : with extension beyond the prostate
Imaging:
Very Low Risk Prostate Cancer
- PSA <10
- Gleason 3+3=6 and less than 2cores
- Clinical Exam: normal
Management Options
- Active Surveillance
- Open Radical Prostatectomy
- Robotic Radical Prostatectomy
- Radiation Therapy
- Watchful Waiting
Clinical Trials
Resources
Low Risk of Prostate Cancer
- PSA 0-10
- Gleason 3+3=6 and more than 2cores
- Clinical Exam: normal or 1/2 abnormality , one side only
Management Options
These men have a very low risk of dying from prostate cancer and generally do well with most forms of therapy. This is the most common form of prostate cancer.
- Active Surveillance
- Open Radical Prostatectomy
- Robotic Radical Prostatectomy
- Radiation Therapy
- Watchful Waiting
Clinical Trials
Resources
Intermediate Risk Prostate Cancer
- PSA 10-20
- Gleason 3+4 or 4+3
- Clinical Exam: Abnormality that does not extend beyond the boundary of the prostate
Management Options
- Open Radical Prostatectomy
- Robotic Radical Prostatectomy
- Radiation Therapy
- Watchful Waiting
Clinical Trials
Resources
High Risk Prostate Cancer
- PSA >20
- Gleason 4+4 or 4+5, more than 5 cores
- Clinical Exam: Abnormality that extends beyound the prostate with no fixation
Management Options
These men have a much higher risk of recurrence with surgery or radiation or surveillance, and often benefit from more aggressive combination approaches.
- Open Radical Prostatectomy
- Robotic Radical Prostatectomy
- Radiation Therapy and 2- 3 years of hormonal suppresion
- Watchful Waiting
Clinical Trials
- Target: Hedgehog Pathway New Trial Opens for Men with High-Risk Prostate Cancer
- Salvage Radiation Therapy and Enzalutamide: A Winning Combination?
Resources
Very High Risk Prostate Cancer
- Gleason 5+4 or 4+5
- Gleason 4+4 or 4+5 and more than 4 cores
- Clinical Exam
Management Options
- Open Radical Prostatectomy
- Robotic Radical Prostatectomy
- Radiation Therapy
- Watchful Waiting
Clinical Trials
-
NO RESULTS FOUND
Resources
Metastatic
- PSA
- Gleason
- Clinical Exam
Management Options
- Hormone Therapy
- Chemotherapy
- Radium 223
- Immuntherapy
Clinical Trials
-
NO RESULTS FOUND
Resources
©
The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287
